Welcome to our dedicated page for TRAVELERS COMPANIES SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRAVELERS COMPANIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRAVELERS COMPANIES's regulatory disclosures and financial reporting.
TRV: A shareholder filed a Form 144 notice to sell up to 8,572 shares of common stock with an aggregate market value $2,320,728.19. The proposed sale is listed for 10/28/2025 through Fidelity Brokerage Services LLC on the NYSE. Shares outstanding were 223,063,417.
The notice indicates the shares derive from an option granted on 02/04/2020 and acquired on 10/28/2025 with cash payment. It also reports a prior sale by Michael Klein of 10,000 shares on 08/04/2025 for $2,619,855.
The Travelers Companies (TRV) reported stronger Q3 results. Total revenues were $12,470 million, up from $11,904 million a year ago, driven by higher premiums of $11,135 million and net investment income of $1,033 million. Net income rose to $1,888 million from $1,260 million, and diluted EPS increased to $8.24 from $5.42.
Profitability benefited from lower catastrophe losses of $402 million versus $939 million in the prior year period and higher segment income of $1,964 million versus $1,304 million. By segment this quarter, premiums were $5,700 million in Business Insurance, $1,042 million in Bond & Specialty, and $4,393 million in Personal Insurance.
Year to date, operating cash flow was $7,921 million. The company repurchased $625 million of shares in the quarter and paid $250 million in common dividends. Shareholders’ equity increased to $31,609 million as accumulated other comprehensive loss narrowed. TRV also agreed to sell its Canadian personal and most commercial insurance business for approximately $2.4 billion, retaining surety in Canada; the sale is subject to approvals and expected to close in the first quarter of 2026.
The Travelers Companies, Inc. (TRV) announced quarterly results for the period ended September 30, 2025, and made its third‑quarter financial supplement available on its website. The company furnished a press release and the supplement as Exhibits 99.1 and 99.2.
The materials are provided as furnished, not filed, under Form 8‑K General Instruction B.2.
The filing reports that Elizabeth Robinson, a director of The Travelers Companies, Inc. (TRV), received 11,264.077 deferred common stock units on 09/30/2025 as non‑cash compensation under the company’s Deferred Compensation Plan for Non‑Employee Directors. These units convert one‑for‑one into shares of common stock upon distribution, which the director may elect to receive as a lump sum or in annual installments. The reported amount includes 43.583 additional deferred units acquired on 09/30/2025 via the plan’s dividend reinvestment feature. The Form 4 was signed by power of attorney on 10/01/2025.
Russell G. Golden, a director of The Travelers Companies, Inc. (TRV), reported receipt of deferred common stock units as director compensation. On 09/30/2025 he was granted 165.64 deferred common stock units under the companys director deferred compensation plan, credited in lieu of cash compensation at an indicated per-share value of $279.22. After the grants and related holdings, he beneficially owned 4,355.693 common stock units, which include 16.442 units received on 09/30/2025 from dividend reinvestment. These deferred units convert one-for-one into shares on distribution and may be paid either in a lump sum or in annual installments under the plan. The Form 4 was signed by power of attorney on 10/01/2025.
Reporting person: Mojgan M. Lefebvre, EVP & Chief Technology & Operations Officer at The Travelers Companies, Inc. (TRV). The Form 4 discloses transactions on 08/22/2025 in which Ms. Lefebvre exercised 16,820 stock options with an exercise price of $132.58 and thereby acquired 16,820 shares of common stock. The same day she sold those 16,820 shares at a weighted average price of $277.5446, reducing her reported direct common stock holdings to 0 shares. The filing shows 9,213 derivative securities (stock options) remain beneficially owned following the reported activity. The filer certified the Form 4 on 08/26/2025 via power of attorney.
The Travelers Companies, Inc. (TRV) Form 4 shows insider transactions by Vice Chairman William H. Heyman on 08/22/2025. Mr. Heyman exercised stock options to acquire 2,000 shares at an exercise price of $139.83 per share and immediately recorded two sales of 1,000 shares each at $278 and $279. After these transactions his reported direct beneficial ownership in common stock stands at 255,085.534 shares, with additional indirect holdings of 1,704.115 shares through a 401(k) plan, 2,256 shares held by his spouse, and 250 shares held in trust for a stepson. The filing includes the option details (exercise date 08/22/2025; exercisable since 02/02/2024; expiration 02/02/2031) and a signature by power of attorney dated 08/26/2025.
The filing is a Form 144 for The Travelers Companies, Inc. (TRV) reporting a proposed sale of 2,000 shares of Common stock through Fidelity Brokerage Services LLC on the NYSE with an aggregate market value of $557,000 and an approximate sale date of 08/22/2025. The shares are listed as acquired on 08/22/2025 pursuant to an option granted on 02/02/2021, with cash payment. The filer previously sold 2,000 shares on 05/29/2025 for $549,000 and 2,000 shares on 05/30/2025 for $553,000. The notice includes the required representation that the seller is not aware of undisclosed material adverse information and carries the standard signature and criminal-misstatement warning.
The Travelers Companies, Inc. (TRV) Form 144 notice reports a proposed sale of 16,820 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $4,668,296.11, and an approximate sale date of 08/22/2025 on the NYSE. The securities were acquired as options granted on 02/04/2020 and are to be paid for in cash. The filer previously sold 6,149 shares on 05/29/2025 for gross proceeds of $1,682,955.06. The filer attests they are unaware of undisclosed material adverse information.
Insider transaction summary: The Form 4 shows insider Rowland David Donnay, EVP & Co-Chief Investment Officer of The Travelers Companies, Inc. (TRV), reported transactions dated 08/18/2025. The filing records a distribution of 2,034 shares from a GRAT to another trust and a transfer that moved 3,131 shares from indirect trust holdings to direct ownership. After the reported disposition, Mr. Donnay beneficially owned 12,686 shares indirectly (held in trust) and directly held additional shares including 5,837.775 shares in a 401(k) plan and 14,862.385 shares